Construction of an analysis system for antigen-specific immune response in human autoimmunity
Project/Area Number |
25670459
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Collagenous pathology/Allergology
|
Research Institution | The University of Tokyo |
Principal Investigator |
FUJIO KEISHI 東京大学, 医学部附属病院, 講師 (70401114)
|
Project Period (FY) |
2013-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 自己抗原 / T細胞レセプター / 次世代シークエンス / 関節リウマチ / 遺伝子発現解析 |
Outline of Final Research Achievements |
The aim of this project is to analyze the kinetics of autoreactive T cells in autoimmunity using T cell receptor. We performed single-cell transcriptome analysis and TCR repertoire analysis using next-generation sequence in peripheral blood and synovium CD4+ T cells in rheumatoid arthritis (RA). Expanded clones in the joint belonged to CXCR3-CCR6-CXCR5- fraction in the peripheral blood, and they aquired CXCR4 expression and senescent phenotype in the synovium. In the multicolor flowcytometory-based clinical database revealed that CXCR4+ memory T cells are closely associated with disease activity in RA. This research clarified the previously unknown kinetics of pathgenic CD4+ T cell clone in RA.
|
Report
(3 results)
Research Products
(9 results)
-
-
[Journal Article] Transcription factor early growth response 3 is associated with the TGF-β1 expression and the regulatory activity of CD4-positive T cells in vivo.2013
Author(s)
Sumitomo S, Fujio K, Okamura T, Morita K, Ishigaki K, Suzukawa K, Kanaya K, Kondo K, Yamasoba T, Furukawa A, Kitahara N, Shoda H, Shibuya M, Okamoto A, Yamamoto K.
-
Journal Title
J Immunol
Volume: 191
Issue: 5
Pages: 2351-9
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-